13 Hanover Square
London, London, W1S 1HL England
FTSE 100 (June 30, 2015)
Hikma Pharmaceuticals seeks the right prescription for generic drug success. The company makes some 700 branded and unbranded generic drugs, which are available in a variety of forms and dosage strengths. About 40 product lines are distributed through licensing agreements with other pharmaceutical companies. Hikma's products are distributed to doctors, hospitals, and pharmacies in about 50 nations in North America, Europe, the Middle East, and Africa through its network of sales representatives. The company conducts research and development in areas such as cardiology, anti-infective, neurology, and dermatology. Hikma Pharmaceuticals was founded in 1978 by chairman Samih Darwazah.